Avoiding the unintended consequences of growth in medical care: How might more be worse?

JAMA

Volumn 281, Issue 5, 1999, Pages 446-453

  Fisher, Elliott S ^a   Welch, H Gilbert ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; ECONOMIC DEVELOPMENT; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE INDUSTRY; INVESTMENT; PRIORITY JOURNAL; PROFIT; UNITED STATES;

EID: 0033518516     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.5.446     Document Type: Article

References (75)

1. National Center for Health Statistics. Health, United States 1995. Hyattsville, Md: US Public Health Service; 1996.
2. Wennberg JE, Cooper MM. The Dartmouth Atlas of Health Care in the United States. Chicago, Ill: American Hospital Publishing Inc; 1998.
3. Carlson RJ. The End of Medicine. New York, NY: Wiley; 1975.
4. Illich I. Medical Nemesis: The Expropriation of Health. New York, NY: Random House; 1976.
5. McKeown T. The Role of Medicine: Dream, Mirage, or Nemesis? Princeton, NJ: Princeton University Press; 1979.
6. Beeson PB. Changes in medical therapy during the past half century. Medicine. 1980;59:79-99.
7. Levine S, Feldman JJ, Elinson J. Does medicine do any good? In: Mechanic D, ed. Handbook for Health, Health Care, and the Health Professions. New York, NY: Free Press; 1983:394-404.
8. Bunker JP, Frazier HS, Mosteller F. Improving health: measuring effects of medical care. Milbank Q. 1994; 72:225-258.
9. Dyson DC, Danbe KH, Bamber JA, et al. Monitoring women at risk for preterm labor. N Engl J Med. 1998;338:15-19.
10. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412.
11. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 1997;350:461-468.
12. Newhouse J. Free for All. Cambridge, Mass: Harvard University Press; 1993.
13. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 1995;333:573-578.
14. Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? N Engl J Med. 1996;334:1441-1447.
15. Verrilli D, Welch HG. The impact of diagnostic testing on therapeutic interventions. JAMA. 1996;275: 1189-1191.
16. Urban BA, Fishman EK, Kuhlman JE, Kawashima A, Hennessey JG, Siegelman SS. Detection of focal hepatic lesions with spiral CT: comparison of 4- and 8-mm interscan spacing. AJR Am J Roentgenol. 1993;160: 783-785.
17. Tanasescu DE, Waxman AD, Drickman MV, et al. Liver scintigraphy in colon carcinoma: correlation with modified Duke pathological classification. Radiology. 1982;145:453-455.
18. Welch HG, Burke W. Uncertainties in genetic testing for chronic disease. JAMA. 1998;280:1525-1528.
19. Kornick J, Trefelner E, McCarthy S, Lange R, Lynch K, Jokl P. Meniscal abnormalities in the asymptomatic population at MR imaging. Radiology. 1990;177: 463-465.
20. Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994;331:69-73.
21. Lederle FA, Walker JM, Reinke DB. Selective screening for abdominal aortic aneurysms with physical examination and ultrasound. Arch Intern Med. 1988;148:1753-1756.
22. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154:1838-1840.
23. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601-1606.
24. Moser KM, Fedullo PF, LitteJohn JK, Crawford R. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 1994; 271:223-225.
25. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
26. National Center for Health Statistics, US Department of Health and Human Services. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Household Adult and Laboratory Data files [CD-ROM]. Hyattsville, Md: Centers for Disease Control and Prevention; 1996. Public use data file documentation No. 76200.
27. Black WC, Welch HG. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993;328: 1237-1243.
28. Birkett NJ, Evans CE, Haynes RB, et al. Hypertension control in two Canadian communities: evidence for better treatment and overlabelling. J Hypertens. 1986;4:369-374.
29. Hampton ML, Anderson J, Lavizzo BS, Bergman AB. Sickle cell nondisease. AJDC. 1974;128:58-61.
30. Cadman D, Chambers LW, Walter SD, Ferguson R, Johnston N, McNamee J. Evaluation of public health preschool child developmental screening: the process and outcomes of a community program. Am J Public Health. 1987;77:45-51.
31. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and over-treatment of Lyme disease: an observational study. Ann Intern Med. 1998;128:354-362.
32. Bergman AB, Stamm SJ. The morbidity of cardiac nondisease in schoolchildren. N Engl J Med. 1967; 276:1008-1013.
33. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid: a "normal" finding in Finland: a systematic autopsy study. Cancer. 1985;56:531-538.
34. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer. 1987;56:814-819.
35. Montie JE, Wood DP Jr, Pontes E, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cytoprostatectomy specimens removed for bladder cancer. Cancer. 1989;63:381-385.
36. Beam CA, Layde PM, Sullivan DC. Variability in the interpretation of screening mammograms by US radiologists. Arch Intern Med. 1996;156:209-213.
37. Elmore JG, Wells CK, Lee CH, Howard DH, Feinstein AR. Variability in radiologists' interpretations of mammograms. N Engl J Med. 1994;331:1493-1499.
38. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol. 1991;15:209-221.
39. Schnitt SJ, Connolly JL, Tavassoli FA, et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol. 1992;16:1133-1143.
40. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol. 1996;27:528-531.
41. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications. JAMA. 1998;279:526-531.
42. Fisher ES, Wennberg JE, Stukel TA, Sharp S. Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven. N Engl J Med. 1994;331:989-995.
43. Pritchard RS, Fisher ES, Teno JM, et al. Influence of patient preference and local health system characteristics on the place of death. J Am Geriatr Soc. 1998; 46:1242-1250.
44. Strauss MJ, LoGerfo JP, Yeltatzie JA, Temkin N, Hudson LD. Rationing of intensive care unit services: an everyday occurrence. JAMA. 1986;255:1143-1146.
45. Tu JV, Naylor CD, Kumer D, DeBuono BA, McNeil BJ, Hannan EL. Coronary artery bypass graft surgery in Ontario and New York State: which rate is right. Ann Intern Med. 1997;126:13-19.
46. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-570.
47. Collaborators NASCET. Beneficial effect of carotid endarterectomy for symptomatic patients with high grade stenosis. N Engl J Med. 1991;325:445-453.
48. Executive Committee for the Asymptomatic Atherosclerosis Study. Endartectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
49. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med. 1996;124:577-584.
50. Nease RF Jr, Kneeland T, O'Connor GT, et al, for the Ischemic Heart Disease Patient Outcomes Research Team. Variation in patient utilities for outcomes of the management of chronic stable angina: implications for clinical practice guidelines. JAMA. 1995; 273:1185-1190.
51. Barry MJ, Fowler FJ Jr, Mulley AG Jr, Henderson JV Jr, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care. 1995;33:771-782.
52. Wennberg DE, Lucas FL, Birkmeyer JD, Brendenberg CE, Fisher ES. Variation in endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA. 1998;279: 1278-1281.
53. Matchar DB, Oddone EZ, McCrory DC, et al. Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Health Serv Res. 1997;32:325-342.
54. Scherkenbach WW. The Deming Route to Quality and Productivity. Rockville, Md: Mercury Press; 1991
55. Berwick DM. Controlling variation in health care: a consultation from Walter Shewhart. Med Care. 1991; 29:1212-1225.
56. Connors AF, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996;276:889-897.
57. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604-1608.
58. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.
59. Steinbrook R. Patients with multiple chronic conditions: how many medications are enough? N Engl J Med. 1998;338:1541-1542.
60. Kiefe CI, Funkhouser E, Fouad MN, May DS. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med. 1998;13:357-365.
61. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation. 1995;92:2841-2847.
62. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-121.
63. Leape LL. Error in medicine. JAMA. 1994;272: 1851-1857.
64. Chrischilles EA, Segar ET, Wallace RB. Self reported adverse drug reactions and related resource use. Ann Intern Med. 1992;117:634-640.
65. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29-34.
66. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279: 1200-1205.
67. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370-376.
68. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The quality in Australian health care study. Med J Aust 1995;163:458-471.
69. Eddy DM. The challenge. JAMA. 1990;263:287-290.
70. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA. 1998;280:975-980.
71. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. New York, NY: Churchill Livingstone; 1997.
72. Kuhn TS. The Structure of Scientific Revolutions. Chicago, Ill: University of Chicago Press; 1970.
73. Deyo RA, Psaty BM, Simon G, Wagner EH, Omenn GS. The messenger under attack: intimidation of researchers by special-interest groups. N Engl J Med. 1997;336:1176-1180.
74. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990;263:1385-1389.
75. Kassirer JP, Angell M. Financial conflicts of interest in biomedical research. N Engl J Med. 1993;329: 570-571.